Tocilizumab Raises GI Risks in Rheumatoid Arthritis | MedPage Today
Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis | Infectious Diseases of Poverty | Full Text
Low immunogenicity of tocilizumab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases
Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis - ScienceDirect
Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome
Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases - Tanaka - 2011 - FEBS Letters - Wiley Online Library
A review of sarilumab for the treatment of rheumatoid arthritis | Immunotherapy
Tocilizumab in the treatment of adult rheumatoid arthritis | Immunotherapy
Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis | Therapeutic Delivery
Figure 1 | Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy
Frontiers | Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19 | Pharmacology
JCI - IL-6 polymorphisms: a useful genetic tool for inflammation research?
How is Actemra® (tocilizumab) for GCA believed to work?
Frontiers | Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis | Pharmacology
Tocilizumab-Atlizumab Overview - Creative Biolabs
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era
![The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/10322/1/fig-3-full.png "The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]")
The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]
Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis | Therapeutic Delivery
Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine | Full Text
About ACTEMRA® (tocilizumab) Treatment Info for Healthcare Professionals
Figure 5 | The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine | Full Text
Interleukin‑6 signaling blockade treatment for cytokine release syndrome in COVID‑19 (Review)
Actemra | Uses, Safety Info & Comparison to Other RA Drugs
Actemra Shortage: What to Do If You Can't Access Tocilizumab
